AHA Coding Clinic® for HCPCS - 2005 Issue 3; FOR your INFORMATION

Newly-approved drugs and biologicals eligible for pass-through status

As you will note in Fig. 5, the following drugs and biologicals were designated as eligible for pass-through status under the OPPS effective July 1, 2005. Fig. 5 HCPCSAPCSILong descriptorC9127 9127 G Injection, Paclitaxel Protein Bound Particles, per 1 mg C9128 9128 G Injection, Pegaptiamib Sodium, per 0.3 mg C9129 9129 G Injection, Clofarabine, per 1 mg J8501* 0868 G Aprepitant, oral, 5 mg *J8501 was approved for pass-through status effective April 6, 2005 ...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.

Thank you for choosing Find-A-Code, please Sign In to remove ads.